Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mahreen Arooj

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Plos One|May 10, 2013
A combination of receptor-based pharmacophore modeling & QM techniques for identification of human chymase inhibitorsMahreen Arooj, Sugunadevi Sakkiah, Songmi Kim, et al.
Environmental Science and Pollution Research International|January 7, 2023
Doping matters in carbon nanomaterial efficiency in environmental remediationJavad B M Parambath, Fatima Abla, Mahreen Arooj, et al.
European Journal of Medicinal Chemistry|March 1, 2019
Synthesis of new arylsulfonylspiroimidazolidine-2',4'-diones and study of their effect on stimulation of insulin release from MIN6 cell line, inhibition of human aldose reductase, sorbitol accumulations in various tissues and oxidative stressZafar Iqbal, Grant Morahan, Mahreen Arooj, et al.
Plos One|February 6, 2013
Identification of inhibitor binding site in human sirtuin 2 using molecular docking and dynamics simulationsSugunadevi Sakkiah, Mahreen Arooj, Manian Rajesh Kumar, et al.
Computational and Structural Biotechnology Journal|January 29, 2021
Identification and characterisation of putative drug binding sites in human ATP-binding cassette B5 (ABCB5) transporterLokeswari P Tangella, Mahreen Arooj, Evelyne Deplazes, et al.
Chemical Biology & Drug Design|July 28, 2012
Computational studies of novel chymase inhibitors against cardiovascular and allergic diseases: mechanism and inhibitionMahreen Arooj, Sundarapandian Thangapandian, Shalini John, et al.
Molecules (Basel, Switzerland)|October 17, 2013
Orbital interaction and electron density transfer in PdII([9]aneB2A)L2 complexes: theoretical approachesOck Keum Kwak, Mahreen Arooj, Yong-Jin Yoon, et al.
Plos One|May 3, 2013
Molecular modeling study for inhibition mechanism of human chymase and its application in inhibitor designMahreen Arooj, Songmi Kim, Sugunadevi Sakkiah, et al.
Proteins|August 22, 2014
Finding off-targets, biological pathways, and target diseases for chymase inhibitors via structure-based systems biology approachMahreen Arooj, Sugunadevi Sakkiah, Guang Ping Cao, et al.
International Journal of Molecular Sciences|January 25, 2012
3D QSAR pharmacophore modeling, in silico screening, and density functional theory (DFT) approaches for identification of human chymase inhibitorsMahreen Arooj, Sundarapandian Thangapandian, Shalini John, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Plos One|May 10, 2013
A combination of receptor-based pharmacophore modeling & QM techniques for identification of human chymase inhibitorsMahreen Arooj, Sugunadevi Sakkiah, Songmi Kim, et al.
Environmental Science and Pollution Research International|January 7, 2023
Doping matters in carbon nanomaterial efficiency in environmental remediationJavad B M Parambath, Fatima Abla, Mahreen Arooj, et al.
European Journal of Medicinal Chemistry|March 1, 2019
Synthesis of new arylsulfonylspiroimidazolidine-2',4'-diones and study of their effect on stimulation of insulin release from MIN6 cell line, inhibition of human aldose reductase, sorbitol accumulations in various tissues and oxidative stressZafar Iqbal, Grant Morahan, Mahreen Arooj, et al.
Plos One|February 6, 2013
Identification of inhibitor binding site in human sirtuin 2 using molecular docking and dynamics simulationsSugunadevi Sakkiah, Mahreen Arooj, Manian Rajesh Kumar, et al.
Computational and Structural Biotechnology Journal|January 29, 2021
Identification and characterisation of putative drug binding sites in human ATP-binding cassette B5 (ABCB5) transporterLokeswari P Tangella, Mahreen Arooj, Evelyne Deplazes, et al.
Chemical Biology & Drug Design|July 28, 2012
Computational studies of novel chymase inhibitors against cardiovascular and allergic diseases: mechanism and inhibitionMahreen Arooj, Sundarapandian Thangapandian, Shalini John, et al.
Molecules (Basel, Switzerland)|October 17, 2013
Orbital interaction and electron density transfer in PdII([9]aneB2A)L2 complexes: theoretical approachesOck Keum Kwak, Mahreen Arooj, Yong-Jin Yoon, et al.
Plos One|May 3, 2013
Molecular modeling study for inhibition mechanism of human chymase and its application in inhibitor designMahreen Arooj, Songmi Kim, Sugunadevi Sakkiah, et al.
Proteins|August 22, 2014
Finding off-targets, biological pathways, and target diseases for chymase inhibitors via structure-based systems biology approachMahreen Arooj, Sugunadevi Sakkiah, Guang Ping Cao, et al.
International Journal of Molecular Sciences|January 25, 2012
3D QSAR pharmacophore modeling, in silico screening, and density functional theory (DFT) approaches for identification of human chymase inhibitorsMahreen Arooj, Sundarapandian Thangapandian, Shalini John, et al.
Pageof 3